NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares ·
—
Market cap
—
52-week range
—
Volume
—
Previous close
—
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) is held by 4 tracked hedge fund(s). Largest tracked holder: Duquesne Family Office.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| Duquesne Family Office Stanley Druckenmiller |
2.9% | 3.1M | $98M | — | $28.37 | 2026-03-31 |
| MAVERICK CAPITAL LTD Lee Ainslie |
0.8% | 2.2M | $70M | ▲ 15% (+292K) | $24.40 | 2026-03-31 |
| Castle Hook Partners LP Castle Hook Partners LP |
0.1% | 1.0M | $33M | ▼ 3.9% (−42K) | $35.08 | 2026-03-31 |
| Slate Path Capital LP David Greenspan |
0.1% | 319K | $10M | — | $25.70 | 2026-03-31 |
FAQ ▾
Which hedge funds hold NAMS?
Tracked holders include: Duquesne Family Office, MAVERICK CAPITAL LTD, Castle Hook Partners LP, Slate Path Capital LP.
How much smart money owns NAMS?
4 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading NAMS?
No tracked Congressional trades in NAMS on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings · Not investment advice ▾
Ownership from SEC filings; price from market data.
Published by WealthFile · Not investment advice.